Rheumatologists should exercise caution in interpreting clinical trial results, with a particular awareness of potential ...
The FDA approved combination imlunestrant plus abemaciclib for adults with hormone therapy-resistant estrogen ...
The United States Special Senate Committee on Aging recently held the first-ever congressional hearing on menopause, ...
Results presented at the American Orthopaedic Foot & Ankle Society Annual Meeting showed patients who underwent a minimally invasive Lapidus procedure for hallux valgus had similar outcomes as those ...
The Myopia Collective added 22 new “change agents,” as well as its first group of 19 student change agents, to foster greater support for and awareness of childhood myopia treatment, according to a ...
In the past, the CDC’s Advisory Committee on Immunization Practices routinely issued recommendations on seasonal influenza ...
The FDA has approved Fayuvi to treat children with mucopolysaccharidosis type IIIA, or Sanfilippo syndrome type A. “Gene therapy holds tremendous promise for rare diseases like Sanfilippo syndrome ...
Lawmakers questioned Nicole Saphier, MD, on abortion bans, vaccines and other preventive health issues during Wednesday’s ...
The FDA has approved finerenone as a therapy to lower urinary albumin-to-creatinine ratio among adults with chronic kidney ...
In a new analysis of the SELECT trial published in JAMA Cardiology, semaglutide 2.4 mg improved clinical outcomes compared ...
The inflection point has arrived.More than a dozen studies presented at ASCO Annual Meeting added to a growing volume of research that suggests GLP-1 receptor agonists may protect against several ...
In this video, Adam Friedman, MD, FAAD, emphasized the need for physicians to address misperceptions in atopic dermatitis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results